Epidemiological and Translational Study of Calprotectin and Atherosclerotic Cardiovascular Disease
The findings suggest that calprotectin may serve as a mechanistically informed biomarker for ASCVD, independent of traditional and contemporary cardiovascular risk factors and biomarkers. However, its clinical utility warrants further evaluation.
Authors
- Colby Ayers (ORCID: https://orcid.org/0000-0003-2060-2263)
- Somanathapura K. NaveenKumar (ORCID: https://orcid.org/0000-0002-8991-5041)
- Lyndsay Kluge
- Jarett D. Berry (ORCID: https://orcid.org/0000-0002-5004-8155)
- Katarína Kmeťová (ORCID: https://orcid.org/0000-0002-2730-4587)
- Wenying Liang (ORCID: https://orcid.org/0000-0001-9985-6674)
- James A. de Lemos (ORCID: https://orcid.org/0000-0003-2211-7261)
- Yu Zuo (ORCID: https://orcid.org/0000-0001-6721-7755)
- Sherwin Navaz
- Jason S. Knight (ORCID: https://orcid.org/0000-0003-0995-9771)
- Anand K. Rohatgi (ORCID: https://orcid.org/0000-0003-0164-2382)
- Kavya Sugur
- Amil Shah
- Emily Chong
Institutions
- The University of Texas at Tyler (US)
- University of Michigan (US)
- The University of Texas Southwestern Medical Center (US)
Publication Details
- Journal
- JAMA Cardiology
- Published
- 2025-05-07
- DOI
- https://doi.org/10.1001/jamacardio.2025.0945
- Citations
- 4
- Primary Topic
- S100 Proteins and Annexins
- Type
- article
- Field-Weighted Citation Impact
- 3.22